articleTop 1% cited
Long-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome
Archives of Dermatology · 2003 · Vol. 139(7) · pp. 857–66
Abstract
Patients with MF and SS have varying risks for disease progression or death. The most important clinical predictive factors for survival include patient age, T classification, and the presence of extracutaneous disease. The significant disease-specific survival differences between different clinical stages validate the usefulness of the present MF clinical staging system of the National Cancer Institute.
Cutaneous lymphoproliferative disorders researchLymphoma Diagnosis and TreatmentT-cell and Retrovirus StudiesMedicineMycosis fungoidesStage (stratigraphy)Internal medicineDiseaseUnivariate analysisPopulationRelative survivalLymphomaRetrospective cohort study
MeSH terms
Actuarial AnalysisAdolescentAdultAgedAged, 80 and overChildFemaleHumansMaleMiddle AgedMycosis FungoidesPrognosisRetrospective StudiesRisk FactorsSezary Syndrome
Citations
648
FWCI
14.53
field-weighted impact
References
32
Percentile
99%
vs. same field & year
Citations per year
Cited by
WHO-EORTC classification for cutaneous lymphomas
Blood · 2005 · 3,781 citations
References
World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues
Annals of Oncology · 2002 · 4,639 citations
A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
Biometrika · 1965 · 3,347 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.